RL

Ricky Lijing Sun

Partner at Bain Capital

Greater Boston

Overview

Work Experience

  • Partner, Bain Capital

    2020 - Current

  • Managing Director, Bain Capital Life Sciences

    2018 - 2020

  • Principal, Bain Capital Life Sciences

    2016 - 2018

  • Member Board of Directors

    2022

  • Board Member

    2022

  • Board Member

    2021

  • Board Member

    2019

  • Board Of Directors

    2018 - 2022

  • Board Observer

    2019 - 2021

  • Board Observer

    2017 - 2018

  • Director of Corporate Development & Strategy

    2015 - 2016

    - Led technical, commercial & financial analyses of multiple M&A opportunities. Partnered with BD to construct key terms in deal / term sheet negotiations for both in-licensing and M&A - Led TA strategy development in neurology and non-malignant hematology by providing commercial point of view for existing and new disease areas of growth for the company - Collaborated with New Product Commercialization team by recommending and defending robust methodologies and frameworks for effectively communicating opportunity assessments.

  • Associate Director Commercial Assessment and Disease Strategy

    2013 - 2014

    Business development, in-licensing, M&A, corporate disease strategy

Relevant Websites